As healthcare professionals, we encounter pyrexia, or fever, regularly in clinical practice. Despite its common occurrence, its management can be complex, necessitating a comprehensive understanding of its etiology, pathophysiology, and treatment options.
Pyrexia is a physiological response to various conditions, most commonly infections. It results from the release of pyrogens, which reset the hypothalamic temperature set-point, leading to increased body temperature. Understanding the underlying cause is crucial in managing pyrexia effectively.
Assessment of the febrile patient should include a thorough history and physical examination. Key factors to consider are the duration and pattern of the fever, associated symptoms, and potential exposure to infectious agents. Laboratory investigations, such as complete blood count, inflammatory markers, and cultures, can provide valuable information.
Treatment of pyrexia primarily focuses on addressing the underlying cause. In cases of infection, appropriate antibiotics should be administered. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs, can be used to alleviate discomfort but should not replace the treatment of the underlying cause. In some cases, pyrexia can be a helpful physiological response, enhancing immune function and inhibiting pathogen growth.
Special considerations should be given to immunocompromised patients, as their fevers may indicate serious infections. Elderly patients may present atypically, with confusion or falls instead of fever. In neonates, pyrexia may be the only sign of serious bacterial infection and warrants immediate investigation.
In conclusion, managing pyrexia in clinical practice requires a comprehensive approach, understanding its etiology, conducting a thorough assessment, and implementing appropriate treatment. Special attention should be given to vulnerable populations. As healthcare professionals, our role is not just to treat the fever, but to understand and address its underlying cause.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation